Article Details
Retrieved on: 2022-03-06 07:59:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
New York: Pfizer Inc. announced results from the CLOVER trial (CLOstridium difficile Vaccine Efficacy TRial), a pivotal Phase 3 study evaluating ...
Article found on: medicaldialogues.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here